September 9
2020
More Early Phase Prevention Trials data now available.
The following Early Phase Prevention Trials data is now available. You can learn more about these trials at cdas.cancer.gov/eppt/ and request access to the data here.
Phase I Trial of Berberine in Subjects with Ulcerative Colitis (NWU2014-03-01)
Phase Ib Biomarker Trial of Naproxen in patients at risk for DNA Mismatch Repair Deficient Colorectal Cancer (MDA2013-01-02)
September 9
2020
The Memorial Sloan-Kettering Lung Study data is now available.
You can learn more about the available Memorial Sloan-Kettering Lung Study data at https://cdas.cancer.gov/mem/.
September 9
2020
HIP Breast Cancer Screening Trial data now available.
You can learn more about the HIP Breast Cancer Screening Trial data at https://cdas.cancer.gov/hipb/ .
August 8
2020
PLCO EEMS Round 31 open for preliminary applications from Aug 21, 2020 to Feb 17, 2021
Preliminary applications will only be accepted from August 21, 2020 to February 17, 2021. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.
The full application deadline is April 2, 2021. The full applications will undergo panel review and final outcome notifications will be sent in early June 2021.
Information is available regarding the PLCO trial and PLCO biospecimens.
Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.
If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.
August 8
2020
IDATA Biospecimen Round 6 open for preliminary applications from Aug 14, 2020 to Feb 12, 2021
Preliminary applications will only be accepted from August 14, 2020 to February 12, 2021. If you plan to submit an IDATA Biospecimen application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.
The full application deadline is March 30, 2021. The full applications will undergo panel review and final outcome notifications will be sent by the end of May 2021.
Information is available regarding the IDATA study and IDATA biospecimens.
Please visit the IDATA Application for Biospecimens page to preview instructions about the process, review the IDATA Biospecimen Policies and Procedures, and begin an IDATA Preliminary Application for Biospecimens.
If you have any questions, please contact CDAS staff at cdas-idatabio@imsweb.com